Lithium Ion

Lithium Ion

SCHEMBL7175365

OCc1cn2c(n1)SCC2.[Al+3].[H-].[H-].[H-].[H-].[Li+]

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.45
KMT2A Q03164 7/20 0.44
MEN1 O00255 6/20 0.44
TP53 P04637 1/20 0.44
GLA P06280 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
NPC1 O15118 7/20 0.42
RAB9A P51151 7/20 0.42
ALDH1A1 P00352 5/20 0.42
GAA P10253 3/20 0.42
KDM4E B2RXH2 3/20 0.42
LMNA P02545 2/20 0.42
NFKB1 P19838 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42
NSD2 O96028 1/20 0.42
ALPL P05186 1/20 0.42
POLB P06746 1/20 0.42
ALPI P09923 1/20 0.42
ALPG P10696 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7181038 0.95 MAPT (0.49) MAPTKMT2AMEN1TP53GLA
SCHEMBL7200327 0.82 MAPT (0.40) MAPTKMT2AMEN1TP53GLA
SCHEMBL8845829 0.79 KMT2A (0.42) MAPTKMT2AMEN1TP53GLA
SCHEMBL1365426 0.77 MAPT (0.47) MAPTKMT2AMEN1TP53GLA
SCHEMBL17196022 0.75 MAPT (0.45) MAPTKMT2AMEN1TP53GLA
SCHEMBL19185513 0.73 MAPT (0.46) MAPTKMT2AMEN1TP53GLA
SCHEMBL9840784 0.71 MAPT (0.50) MAPTKMT2AMEN1TP53GLA
SCHEMBL7186322 0.71 KMT2A (0.45) MAPTKMT2AMEN1TP53GLA
SCHEMBL8339941 0.67
SCHEMBL15013398 0.65 SMN1; SMN2 (0.40) MAPTKMT2AMEN1TP53GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0758240-B1 PHARMACEUTICAL FORMULATIONS CONTAINING A BETA-LACTAMASE INHIBITING PENEM IN COMBINATION WITH A BETA-LACTAM ANTIBIOTIC AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIONS SMITHKLINE BEECHAM PLC (GB) 2003-10-29 EP disclosed
US-6600035-B1 Multistage reaction of forming penicillin antibiotics SMITHKLINE BEECHAM P.L.C. (GB) 2003-07-29 US disclosed